Related Articles
Identification of microRNAs involved in gefitinib resistance of non‑small‑cell lung cancer through the insulin‑like growth factor receptor 1 signaling pathway
Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells
Downregulation of exosomal miR‑1273a increases cisplatin resistance of non‑small cell lung cancer by upregulating the expression of syndecan binding protein
Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells